Skip to main content
Clinical Trials/CTRI/2019/06/019859
CTRI/2019/06/019859
Not yet recruiting
未知

A COMPARATIVE CLINICAL STUDY TO EVALUATE EFFECTS OF VIDALAKA, SEKA AND GHRITAPANA IN SHUSHKAKSHIPAKA W.S.R MEIBOMIAN GLAND DYSFUNCTIO

RISHIKUL CAMPUS0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
RISHIKUL CAMPUS
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
RISHIKUL CAMPUS

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients presenting with signs and symptoms of Shushkakshipaka and meibomian Gland Dysfunction
  • 2\. Age 20\-60 years
  • 3\. Visual acuity 6/6 both eyes, with or without glasses.

Exclusion Criteria

  • 1\. Patient having visual acuity \< 6/6 \& N6 with or without glasses
  • 2\. Patient having infective anterior segment disorders, lid disorders etc.
  • 3\. Patient suffering from specific eye lid disorders like tumor, skin allergies (acne rosacae), ectropion, entropion, lagophthalmos, aqueous deficiency dry eye etc.
  • 4\. Systemic diseases like DM, HTN, RA.

Outcomes

Primary Outcomes

Not specified

Similar Trials